Protagenic Therapeutics Inc (PTIX)

$3.06 +0.07 (2.34%)
Market Cap 1.80M
Revenue (ttm) 0.00
Net Income (ttm) -5.53M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 32,700
Avg Vol 3,390,458
Day's Range N/A - N/A
Shares Out 589,000.00
Stochastic %K 45%
Beta 0.38
Analysts Strong Buy
Price Target $4.00

Company Profile

Protagenic Therapeutics, Inc. operates as a pharmaceutical company specializing in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. Protagenic Therapeutics, Inc. was founded in 2004 and is based in Santa Barbara, California.

Industry: Biotechnology
Sector: Healthcare
Phone: (805) 699-5596
Address:
701 Anacapa Street, Suite C, Santa Barbara, United States
MS1974
MS1974 Oct. 24 at 6:22 PM
$PTIX Moment
0 · Reply
sadie444
sadie444 Oct. 23 at 12:26 PM
$PTIX what the heck was that?! There is no news out, but it looks like someone either tried to manipulate and take out some stop losses or?
1 · Reply
sadie444
sadie444 Oct. 17 at 8:14 PM
$PTIX we’re very overdue for top line data coming out, as the study was to be completed end of September. I am hoping that we will receive reports out early next week.
0 · Reply
sadie444
sadie444 Oct. 16 at 6:38 PM
$PTIX Wow, talk about low volume!
0 · Reply
sadie444
sadie444 Oct. 14 at 10:16 PM
$PTIX nice after-hours upswing. This is way oversold and should see a reversal
0 · Reply
MarbleMonster1
MarbleMonster1 Oct. 13 at 8:50 PM
$PTIX wrong way !
0 · Reply
_CircuitBreaker
_CircuitBreaker Oct. 9 at 10:50 PM
Keep a close watch on CMCT! $WAI $SLGL $PTIX $PBM 4
0 · Reply
MS1974
MS1974 Oct. 9 at 4:05 PM
$PTIX Booom Booom Booom💥15$👊👊👊
0 · Reply
SwingTraderra
SwingTraderra Oct. 9 at 3:38 PM
$PTIX there we go. $8
0 · Reply
MS1974
MS1974 Oct. 9 at 2:38 PM
$PTIX 15$☝️
0 · Reply
Latest News on PTIX
Protagenic Therapeutics Provides Update on Form 10-Q Filing Timeline and Nasdaq Compliance

Aug 22, 2025, 5:25 PM EDT - 2 months ago

Protagenic Therapeutics Provides Update on Form 10-Q Filing Timeline and Nasdaq Compliance

Protagenic Therapeutics Advances PT00114 into Multiple-Dose Phase 1 Trial; Positioning for Phase 2 in Stress & Mood Disorders

Aug 21, 2025, 8:12 AM EDT - 2 months ago

Protagenic Therapeutics Advances PT00114 into Multiple-Dose Phase 1 Trial; Positioning for Phase 2 in Stress & Mood Disorders

Protagenic Therapeutics Receives $3.1 Million from Recent Warrant Activity

May 21, 2025, 9:15 AM EDT - 5 months ago

Protagenic Therapeutics Receives $3.1 Million from Recent Warrant Activity

Gold Gains Over 1%; Protagenic Therapeutics Shares Spike Higher

May 19, 2025, 1:40 PM EDT - 5 months ago

Gold Gains Over 1%; Protagenic Therapeutics Shares Spike Higher

Protagenic Therapeutics and Phytanix Announce Business Combination to form Neuroactive Biopharmaceutical Company with Six Drug Candidates in Development including Treatments for Obesity and Metabolic Disorders

May 19, 2025, 7:43 AM EDT - 5 months ago

Protagenic Therapeutics and Phytanix Announce Business Combination to form Neuroactive Biopharmaceutical Company with Six Drug Candidates in Development including Treatments for Obesity and Metabolic Disorders

Protagenic Therapeutics to Effect 1-for-14 Reverse Stock Split

Apr 29, 2025, 4:00 PM EDT - 6 months ago

Protagenic Therapeutics to Effect 1-for-14 Reverse Stock Split

Protagenic Therapeutics Announces Closing of Private Placement for Aggregate Gross Proceeds of $1.275 Million

Nov 5, 2024, 8:12 AM EST - 1 year ago

Protagenic Therapeutics Announces Closing of Private Placement for Aggregate Gross Proceeds of $1.275 Million

Protagenic Therapeutics Announces Pricing of Private Placement for Aggregate Gross Proceeds of $1.275 Million

Oct 29, 2024, 9:27 AM EDT - 1 year ago

Protagenic Therapeutics Announces Pricing of Private Placement for Aggregate Gross Proceeds of $1.275 Million

Protagenic Therapeutics Completes Enrollment in Single Dose Portion of Phase 1 of Innovative Stress Disorder Trial

May 1, 2024, 8:38 AM EDT - 1 year ago

Protagenic Therapeutics Completes Enrollment in Single Dose Portion of Phase 1 of Innovative Stress Disorder Trial

Protagenic Therapeutics' Innovative Peptide PT00114 to be Highlighted at Boston Summit

Apr 17, 2024, 8:42 AM EDT - 1 year ago

Protagenic Therapeutics' Innovative Peptide PT00114 to be Highlighted at Boston Summit

Protagenic Therapeutics, Inc. (PTIX) Q4 2023 Earnings Call Transcript

Apr 1, 2024, 9:32 PM EDT - 1 year ago

Protagenic Therapeutics, Inc. (PTIX) Q4 2023 Earnings Call Transcript

Protagenic Therapeutics Reports Fourth Quarter and Full Year 2023 Results

Apr 1, 2024, 4:20 PM EDT - 1 year ago

Protagenic Therapeutics Reports Fourth Quarter and Full Year 2023 Results

Protagenic Therapeutics Successfully Concludes Third Cohort in Single Dose Portion of Phase 1 Trial for Stress-Related Neuropsychiatric Disorders

Mar 27, 2024, 8:42 AM EDT - 1 year ago

Protagenic Therapeutics Successfully Concludes Third Cohort in Single Dose Portion of Phase 1 Trial for Stress-Related Neuropsychiatric Disorders

Protagenic Therapeutics Schedules First Q4 and FY 2023 Earnings Call

Mar 25, 2024, 5:00 PM EDT - 1 year ago

Protagenic Therapeutics Schedules First Q4 and FY 2023 Earnings Call

Protagenic Therapeutics Announces Resolution of Nasdaq Deficiency Notice

Mar 21, 2024, 8:41 AM EDT - 1 year ago

Protagenic Therapeutics Announces Resolution of Nasdaq Deficiency Notice

Protagenic Therapeutics Achieves First Clinical Safety Milestone with its Novel Neuropeptide for the Potential Treatment of Stress-Related Disorders

Feb 13, 2024, 8:30 AM EST - 1 year ago

Protagenic Therapeutics Achieves First Clinical Safety Milestone with its Novel Neuropeptide for the Potential Treatment of Stress-Related Disorders

Protagenic Therapeutics Announces Date of Annual Shareholder Meeting

Oct 13, 2023, 9:00 AM EDT - 2 years ago

Protagenic Therapeutics Announces Date of Annual Shareholder Meeting

Protagenic Therapeutics Initiates Phase I/IIa Clinical Trial for Groundbreaking Brain Peptide PT00114

Sep 26, 2023, 8:18 AM EDT - 2 years ago

Protagenic Therapeutics Initiates Phase I/IIa Clinical Trial for Groundbreaking Brain Peptide PT00114

Protagenic Therapeutics to Effect 1-for-4 Reverse Stock Split

Mar 22, 2023, 12:55 PM EDT - 2 years ago

Protagenic Therapeutics to Effect 1-for-4 Reverse Stock Split

Protagenic Therapeutics to Present at the B. Riley Securities Neuro and Ophthalmology Virtual Investor Conference on April 27th

Apr 26, 2022, 8:15 AM EDT - 3 years ago

Protagenic Therapeutics to Present at the B. Riley Securities Neuro and Ophthalmology Virtual Investor Conference on April 27th

Protagenic Therapeutics Announces Third Quarter 2021 Results and Business Update

Nov 16, 2021, 9:58 AM EST - 4 years ago

Protagenic Therapeutics Announces Third Quarter 2021 Results and Business Update

Protagenic Therapeutics to Host Virtual Science Review Wednesday, September 8th at 10 AM ET

Aug 30, 2021, 9:15 AM EDT - 4 years ago

Protagenic Therapeutics to Host Virtual Science Review Wednesday, September 8th at 10 AM ET

Protagenic Therapeutics Announces Second Quarter 2021 Results and Provides Business Update

Aug 17, 2021, 7:45 AM EDT - 4 years ago

Protagenic Therapeutics Announces Second Quarter 2021 Results and Provides Business Update

Protagenic Therapeutics To Start Clinical Trials For Depression Candidate By 2021 End

Jul 26, 2021, 6:31 AM EDT - 4 years ago

Protagenic Therapeutics To Start Clinical Trials For Depression Candidate By 2021 End

Protagenic Therapeutics Updates Timeline for Commencement of Patient Enrollment for PT00114 Clinical Trial

Jul 23, 2021, 4:21 PM EDT - 4 years ago

Protagenic Therapeutics Updates Timeline for Commencement of Patient Enrollment for PT00114 Clinical Trial

Protagenic Therapeutics to Host Webinar with Dr. Maurizio Fava for its Lead Molecule PT00114 on Tuesday, July 13th at 10:00 AM ET

Jul 6, 2021, 6:17 AM EDT - 4 years ago

Protagenic Therapeutics to Host Webinar with Dr. Maurizio Fava for its Lead Molecule PT00114 on Tuesday, July 13th at 10:00 AM ET

Protagenic Therapeutics to Present at the H.C. Wainwright Psychedelics in Psychiatry and Beyond Virtual Conference on June 17th

Jun 16, 2021, 9:15 AM EDT - 4 years ago

Protagenic Therapeutics to Present at the H.C. Wainwright Psychedelics in Psychiatry and Beyond Virtual Conference on June 17th

Protagenic Therapeutics, Inc. Announces Closing of $13.2 Million Public Offering and Uplisting to Nasdaq

Apr 29, 2021, 3:06 PM EDT - 4 years ago

Protagenic Therapeutics, Inc. Announces Closing of $13.2 Million Public Offering and Uplisting to Nasdaq

Protagenic Therapeutics, Inc. Announces Nasdaq Uplisting and Pricing of $13.2 Million Public Offering

Apr 26, 2021, 8:58 PM EDT - 4 years ago

Protagenic Therapeutics, Inc. Announces Nasdaq Uplisting and Pricing of $13.2 Million Public Offering

MS1974
MS1974 Oct. 24 at 6:22 PM
$PTIX Moment
0 · Reply
sadie444
sadie444 Oct. 23 at 12:26 PM
$PTIX what the heck was that?! There is no news out, but it looks like someone either tried to manipulate and take out some stop losses or?
1 · Reply
sadie444
sadie444 Oct. 17 at 8:14 PM
$PTIX we’re very overdue for top line data coming out, as the study was to be completed end of September. I am hoping that we will receive reports out early next week.
0 · Reply
sadie444
sadie444 Oct. 16 at 6:38 PM
$PTIX Wow, talk about low volume!
0 · Reply
sadie444
sadie444 Oct. 14 at 10:16 PM
$PTIX nice after-hours upswing. This is way oversold and should see a reversal
0 · Reply
MarbleMonster1
MarbleMonster1 Oct. 13 at 8:50 PM
$PTIX wrong way !
0 · Reply
_CircuitBreaker
_CircuitBreaker Oct. 9 at 10:50 PM
Keep a close watch on CMCT! $WAI $SLGL $PTIX $PBM 4
0 · Reply
MS1974
MS1974 Oct. 9 at 4:05 PM
$PTIX Booom Booom Booom💥15$👊👊👊
0 · Reply
SwingTraderra
SwingTraderra Oct. 9 at 3:38 PM
$PTIX there we go. $8
0 · Reply
MS1974
MS1974 Oct. 9 at 2:38 PM
$PTIX 15$☝️
0 · Reply
MS1974
MS1974 Oct. 9 at 2:37 PM
$PTIX 💥🚀🚀🚀😎
0 · Reply
MS1974
MS1974 Oct. 9 at 2:04 PM
$PTIX tick tack tick tack moment🚀🚀🚀🚀🚀🚀
0 · Reply
TradeSmart2
TradeSmart2 Oct. 8 at 3:43 PM
$PTIX Warrants looking very cheap to someone ..they just bought 10k
0 · Reply
SwingTraderra
SwingTraderra Oct. 8 at 2:22 AM
$PTIX due for a spike…PT $8
0 · Reply
MS1974
MS1974 Oct. 6 at 7:33 PM
$PTIX $SPRB 😎
0 · Reply
TradeSmart2
TradeSmart2 Oct. 3 at 9:21 PM
$PTIX Though merger oft to a rocky start looking like it will proceed as planned..Good for all shareholders..we should see a Boost from ABTI/Phytanix shareholders Once merger is fully understood. We need more Transparency from company regarding this as well as promised results..which is imminent(timing uncertain) imho
0 · Reply
_CircuitBreaker
_CircuitBreaker Oct. 3 at 12:54 AM
$SLGL $PTIX $PBM $NIVF "
0 · Reply
Orig04
Orig04 Oct. 2 at 1:27 PM
$PTIX They said Quality data will be available in September. We are in Oct 1st week now! Companies are usually careful about what they say. I'm wondering if they didn't mean that a PR about the quality data shall be issued in Sep! If that's the case, it's gonna take a little more wait! Someone else keep me honest plz..
1 · Reply
MS1974
MS1974 Oct. 1 at 10:27 PM
$PTIX News coming,maybe moment huge up!
0 · Reply
Orig04
Orig04 Sep. 30 at 3:10 PM
$PTIX Today's price action boggles my mind!! Holding firm and looking for the quality data PR! Should be anytime now..
0 · Reply
ClintNorthwood
ClintNorthwood Sep. 30 at 2:16 PM
$PTIX the market cap has tripled? WTF!!!!
1 · Reply
sadie444
sadie444 Sep. 30 at 2:02 PM
$PTIX looks like a takedown attempt to see if they can pull out any stop losses prior to the next move. This has happened a couple times prior to spikes so we’ll have to see what happens over the next 48 hours.
0 · Reply